49 results
8-K
EX-99.2
ZVRA
Zevra Therapeutics Inc
20 Nov 23
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
7:36am
policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from
424B3
ZVRA
Zevra Therapeutics Inc
10 Oct 23
Prospectus supplement
5:07pm
-kickback, fraud and abuse, false claims, physician payment transparency, health information privacy and security and other healthcare laws … candidates for which Acer obtains marketing approval. In addition, Acer may be subject to physician payment transparency laws and patient privacy and security
S-4/A
ZVRA
Zevra Therapeutics Inc
6 Oct 23
Registration of securities issued in business combination transactions (amended)
4:06pm
privacy and security and other healthcare laws and regulations, which could expose Acer to sanctions.
Healthcare providers, physicians and third-party … payment transparency laws and patient privacy and security regulation by the U.S. federal government and states and by the foreign jurisdictions
S-4
pos5rpma18nstgkpcjc
28 Sep 23
Registration of securities issued in business combination transactions
9:25pm
425
sf88e
31 Aug 23
Business combination disclosure
8:03am
8-K
EX-2.1
psu3jy ph
31 Aug 23
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
8:01am
424B3
9g9t79ykgjcz
10 Nov 21
Prospectus supplement
5:19pm
424B3
dhto xxbyq
16 Aug 21
Prospectus supplement
12:00am
424B3
nfdw9411kd515cd15dd
12 Jul 21
Prospectus supplement
4:18pm
8-K
EX-10.1
4ieq0p9 pp14gc
2 Jul 21
Entry into a Material Definitive Agreement
4:01pm
424B3
6rdus4d3
13 May 21
Prospectus supplement
9:11pm
424B3
ejfbo9m
11 Mar 21
Prospectus supplement
9:56pm
424B4
8gs0 u5rr
8 Jan 21
Prospectus supplement with pricing info
9:38pm